Sumitomo Chemical

Sector: Manufacturing (Agrochemicals / Pesticides Plant)  |  HQ: India  |  Founded: Not separately disclosed  |  Employees: Not separately disclosed

Listed as: Privately held  | 

Company overview

Sumitomo Chemical operates in the manufacturing segment of the Indian market, with a presence noted in the agrochemicals / pesticides plant category. The company is among the recognised participants in this segment alongside other Indian and multinational players. Operations follow the standard Companies Act 2013 disclosure framework where Sumitomo Chemical is incorporated as a private or public limited company under Indian law, with statutory audit, GST registration under the CGST Act 2017, and applicable sectoral compliance under FSSAI, BIS, MoEF, or sectoral regulators as relevant to the activity. The competitive set in agrochemicals / pesticides plant includes pan-India brands, regional players, and multinational subsidiaries operating in India through wholly-owned or joint-venture structures.

Recent developments

May 2026

Sumitomo Chemical India delivered Q3 FY26 consolidated PAT of Rs. 75.63 Cr [6], with Q4 & FY26 earnings results scheduled for release on May 28, 2026 [3]. The company's governance framework was reinforced through its FY26 compliance filing [1]. Analyst sentiment shows divergence: ICICI Direct maintains a buy recommendation with a target of Rs 515 [9], while Markets Mojo rates the stock a sell [4]. Technical indicators from Economic Times identify bullish signals [7], though Markets Mojo notes recent momentum shifts amid mixed market signals [10]. Long-term investors have realized respectable returns of 48% over the past five years [8], indicating solid performance despite short-term analyst disagreement.

Sources (8)

1. Sumitomo Chemical India Files FY26 Compliance Report, Reinforces Governance - Whalesbook · Whalesbook · Mon, 18 May 2026
2. Sumitomo Chemical India Schedules Q4 & FY26 Earnings Call on May 28, 2026 - scanx.trade · scanx.trade · Fri, 15 May 2026
3. Sumitomo Chemical India Ltd is Rated Sell - Markets Mojo · Markets Mojo · Sun, 10 May 2026
4. Sumitomo Chemical India posts Q3 FY26 consolidated PAT of Rs. 75.63 Cr - Indian Chemical News · Indian Chemical News · Sat, 31 Jan 2026
5. Sumitomo Chemical India - Netweb Technologies among 7 stocks flashing bullish signals, indicating possible uptrend - The Economic Times · The Economic Times · Wed, 06 May 2026
6. Investors in Sumitomo Chemical India (NSE:SUMICHEM) have seen respectable returns of 48% over the past five years - simplywall.st · simplywall.st · Fri, 02 Jan 2026
7. Buy Sumitomo Chemicals; target of Rs 515: ICICI Direct - TradingView · TradingView · Sun, 12 Apr 2026
8. Sumitomo Chemical India Ltd Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo · Markets Mojo · Tue, 12 May 2026

Financial performance and recent trajectory

Disclosed revenue (FY25): Not separately disclosed in segment-wise FY 2024-25 reporting.

Competitive position

Sumitomo Chemical occupies a position in the agrochemicals / pesticides plant category alongside other listed and unlisted Indian players. Competitive intensity in the segment is shaped by raw material cost cycles, distribution depth, branded versus unbranded share, and the regulatory framework governing manufacturing, FSSAI labelling (for food), BIS standards (for engineering goods), or sectoral norms. The principal competitive moats in this category are typically scale, distribution reach, brand trust, and integrated procurement. KAMRIT's project report on agrochemicals / pesticides plant benchmarks new entrant economics against the listed peer cost structure including capex per tonne (or per unit of output), working capital intensity, gross margin band, and the EBITDA delta between organised and unorganised participants.

Key risks

Input cost volatility in the agrochemicals / pesticides plant value chain Competitive intensity from larger Indian groups and multinational subsidiaries Regulatory tightening under FSSAI, BIS, environmental norms, or labour codes

Outlook

Sumitomo Chemical is a participant in the Indian agrochemicals / pesticides plant category, which forms part of the broader Manufacturing space. The Indian agrochemicals / pesticides plant market continues to evolve with rising organised share, premiumisation, distribution expansion, and a regulatory architecture covering the Companies Act 2013, the Income Tax Act 1961, the CGST Act 2017, the Legal Metrology Act 2009, and sectoral statutes including the Food Safety and Standards Act 2006 (for food and beverage subsegments), the Drugs and Cosmetics Act 1940 (for pharmaceutical or healthcare adjacencies), the Environment Protection Act 1986 (for emissions and effluents), and labour codes consolidated under the four 2020 labour codes. In KAMRIT's project report framework for this category, the competitive set typically includes pan-India branded leaders, multinational subsidiaries, mid-sized regional players, and a long tail of MSME participants. The structural attractiveness of the category for new entrants is a function of (a) market growth rate, (b) the share that remains with unorganised or fragmented operators, (c) the cost of regulatory compliance, and (d) the capex intensity of plant and machinery. The KAMRIT bankable DPR for this category structures a new entrant's economics against this competitive landscape. For Sumitomo Chemical specifically, public-domain disclosures provide a baseline view of operations, but segment-wise revenue, EBITDA, capacity utilisation, and forward capex plans are not separately broken out in many cases. Where the company is part of a listed group, the SEBI LODR and the Companies Act 2013 governance framework apply, with statutory audit conducted under SA 700 and CARO 2020 reporting. Where the company is unlisted, the Companies Act 2013 framework continues to govern with reduced public disclosure. The risk and opportunity outlook for Sumitomo Chemical mirrors the broader agrochemicals / pesticides plant category dynamics. Demand-side drivers include rising household consumption, urbanisation, organised retail expansion, and policy support including PLI schemes (where applicable to the segment). Supply-side risks include input cost volatility, regulatory tightening, environmental compliance escalation, and competitive intensity from larger groups or imports. Management quality, balance sheet strength, distribution depth, and the capex execution track record are the differentiators within the peer set. KAMRIT's research desk maintains a baseline reference for Sumitomo Chemical as a peer benchmark within the agrochemicals / pesticides plant category. For investors, lenders, or new entrant promoters seeking a fuller assessment of Sumitomo Chemical, KAMRIT's deep-dive company profile engagement covers financial trajectory, capacity and capex, distribution and customer concentration, regulatory exposure, and the competitive position with named peers.

KAMRIT point of view

Building or competing with Sumitomo?

KAMRIT advises promoters, family offices, and global enterprises evaluating greenfield entry into the manufacturing (agrochemicals / pesticides plant) sector. Our Bankable DPR with Cost Model and ROI benchmarks your project economics against the listed-company cost structure of Sumitomo and peers. The Execution Partnership tier covers everything from incorporation through commissioning. A 20-minute scoping call with our partners is free.

View all 1 related project report → Book a scoping call

Related KAMRIT project reports

These reports use Sumitomo Chemical in benchmarking and competitive analysis sections.

Disclaimer: This profile is compiled by KAMRIT Financial Services LLP for educational and benchmarking purposes only. It is not investment advice, a recommendation to buy or sell securities, or a solicitation. Stock data is provided by Yahoo Finance and may be delayed by up to 20 minutes. Company financial commentary draws on publicly available filings, exchange disclosures, and KAMRIT industry research. Readers should consult a SEBI-registered investment adviser before making investment decisions. KAMRIT is a financial services and compliance firm, not a SEBI-registered investment adviser.